Patents by Inventor Yohann Demont

Yohann Demont has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for ProNGF assay for in vitro diagnosis of cancer in particular breast, thyroid or lung cancer and therapeutic use of ProNGF
    Patent number: 9061045
    Abstract: A ProNGF inhibitor for preparing a drug, said drug being in particular useful for blocking remote dissemination and cell invasion in patients suffering from cancer, in particular breast, thyroid or lung cancer.
    Type: Grant
    Filed: June 26, 2012
    Date of Patent: June 23, 2015
    Assignees: BIOMERIEUX, UNIVERSITE DES SCIENCES ET TECHNOLOGIES DE LILLE
    Inventors: Geneviève Choquet-Kastylevsky, Yohann Demont, Hubert Hondermarck
  • METHOD FOR PRONGF ASSAY FOR IN VITRO DIAGNOSIS OF CANCER IN PARTICULAR BREAST, THYROID OR LUNG CANCER AND THERAPEUTIC USE OF PRONGF
    Publication number: 20130171173
    Abstract: A ProNGF inhibitor for preparing a drug, said drug being in particular useful for blocking remote dissemination and cell invasion in patients suffering from cancer, in particular breast, thyroid or lung cancer.
    Type: Application
    Filed: June 26, 2012
    Publication date: July 4, 2013
    Applicants: UNIVERSITE DES SCIENCES ET TECHNOLOGIES DE LILLE, BIOMERIEUX
    Inventors: Geneviève CHOQUET-KASTYLEVSKY, Yohann DEMONT, Hubert HONDERMARCK
  • Method for prongf assay for in vitro diagnosis of cancer in particular breast, thyroid or lung cancer and therapeutic use of prongf
    Publication number: 20110293636
    Abstract: A ProNGF inhibitor for preparing a drug, said drug being in particular useful for blocking remote dissemination and cell invasion in patients suffering from cancer, in particular breast, thyroid or lung cancer.
    Type: Application
    Filed: July 20, 2011
    Publication date: December 1, 2011
    Applicants: UNIVERSITE DES SCIENCES ET TECHNOLOGIES DE LILLE, BIOMERIEUX
    Inventors: Geneviève Choquet-Kastylevsky, Yohann Demont, Hubert Hondermarck
  • Method for Prongf Assay for in Vitro Diagnosis of Cancer in Particular Breast, Thyroid or Lung Cancer, and Therapeutic Use of Prongf
    Publication number: 20090068200
    Abstract: The present invention concerns a method for in vitro diagnosis of cancer, in particular breast, thyroid or lung cancer, which consists in determining the presence of ProNGF in a biological sample derived from a patient suspected of suffering from cancer, in particular breast, thyroid or lung cancer. Said method may be used for early diagnosis, screening, therapeutic follow-up, prognosis and for diagnosing relapses in cancer and in particular breast, thyroid or lung cancer. The present invention also concerns the use of a ProNGF inhibitor for preparing a drug, said drug being in particular useful for blocking remote dissemination and cell invasion in patients suffering from cancer, in particular breast, thyroid or lung cancer. The invention is applicable in the field of diagnosis and therapeutics.
    Type: Application
    Filed: January 30, 2007
    Publication date: March 12, 2009
    Applicants: BIOMERIEUX, UNIVERSITE DES SCIENCES ET TECHNOLOGIES DE LILLE
    Inventors: Genevieve Choquet-Kastylevsky, Yohann Demont, Hubert Hondermarck